SignatureFD
TNDM icon

SignatureFD’s Tandem Diabetes Care TNDM Stock Holding History

SignatureFD’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.16K Buy
500
+48
+11% +$901 ﹤0.01% 2780
2026
Q2 		$6.82K Sell
452
-25
-5% -$437 ﹤0.01% 2774
2026
Q1 		$9.14K Buy
477
+130
+37% +$2.82K ﹤0.01% 2558
2025
Q4 		$7.63K Buy
347
+115
+50% +$2.08K ﹤0.01% 2540
2025
Q3 		$2.82K Sell
232
-539
-70% -$7.3K ﹤0.01% 2855
2025
Q2 		$14.4K Sell
771
-927
-55% -$18.4K ﹤0.01% 2192
2025
Q1 		$32.5K Sell
1,698
-567
-25% -$16.6K ﹤0.01% 1807
2024
Q4 		$81.6K Buy
2,265
+51
+2% +$1.72K ﹤0.01% 1338
2024
Q3 		$93.9K Sell
2,214
-93
-4% -$3.94K ﹤0.01% 1244
2024
Q2 		$92.9K Buy
2,307
+522
+29% +$21.8K ﹤0.01% 1200
2024
Q1 		$63.2K Buy
1,785
+94
+6% +$2.52K ﹤0.01% 1421
2023
Q4 		$50K Buy
1,691
+1,517
+872% +$31.5K ﹤0.01% 1461
2023
Q3 		$3.61K Buy
174
+58
+50% +$1.59K ﹤0.01% 2603
2023
Q2 		$2.85K Sell
116
-2
-2% -$64 ﹤0.01% 2695
2023
Q1 		$4.79K Sell
118
-448
-79% -$18.5K ﹤0.01% 2521
2022
Q4 		$25.4K Sell
566
-54
-9% -$2.44K ﹤0.01% 1684
2022
Q3 		$30K Buy
620
+319
+106% +$17.5K ﹤0.01% 1555
2022
Q2 		$18K Buy
301
+242
+410% +$19.9K ﹤0.01% 1841
2022
Q1 		$7K Buy
59
+45
+321% +$5.25K ﹤0.01% 2366
2021
Q4 		$2K Buy
+14
New +$1.89K ﹤0.01% 2801
2021
Q3 		– Sell
-1
Closed – – 3210
2021
Q2 		$0 Buy
+1
New +$89 ﹤0.01% 3062
2021
Q1 		– Sell
-1
Closed – – 2829
2020
Q4 		$0 Hold
1
– – ﹤0.01% 2704
2020
Q3 		$0 Hold
1
– – ﹤0.01% 2759
2020
Q2 		$0 Hold
1
– – ﹤0.01% 2667
2020
Q1 		$0 Hold
1
– – ﹤0.01% 2447
2019
Q4 		$0 Hold
1
– – ﹤0.01% 2269
2019
Q3 		$0 Hold
1
– – ﹤0.01% 2202
2019
Q2 		$0 Hold
1
– – ﹤0.01% 2159
2019
Q1 		$0 Buy
+1
New +$53 ﹤0.01% 2058

Other funds holding TNDM

GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Paradice Investment Management
Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

SignatureFD's TNDM Position: Q3 2026 in Review

SignatureFD increased its Tandem Diabetes Care (TNDM) stake by 11% in Q3 2026, buying an estimated $901 and bringing the position to 500 shares worth $8.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

SignatureFD first reported a position in TNDM in Q1 2019 and has held it in 29 quarters since. The position peaked at $93.9K in Q3 2024. 172 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • SignatureFD held 500 shares of Tandem Diabetes Care worth $8.16K as of Q3 2026.
  • SignatureFD bought 48 Tandem Diabetes Care shares in Q3 2026, an estimated $901.
  • Tandem Diabetes Care made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2780 holding.
  • SignatureFD first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 29 quarters since.
  • SignatureFD's Tandem Diabetes Care position peaked at $93.9K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.